Two Sigma Investments
STLN

Two Sigma Investments’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Two Sigma Investments’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945K Buy
307,754
+45,704
+17% +$140K ﹤0.01% 3302
2025
Q4 		$933K Sell
262,050
-16,917
-6% -$62.7K ﹤0.01% 2964
2025
Q3 		$974K Buy
278,967
+802
+0.3% +$2.75K ﹤0.01% 2587
2025
Q2 		$570K Buy
+278,165
New +$695K ﹤0.01% 2527
2023
Q2 		– Sell
-42,775
Closed -$29K – 3261
2023
Q1 		$29K Sell
42,775
-7,717
-15% -$9.85K ﹤0.01% 2820
2022
Q4 		$83.3K Buy
+50,492
New +$142K ﹤0.01% 2533

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's STLN Position: Q1 2026 in Review

Two Sigma Investments increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 17% in Q1 2026, buying an estimated $140K and bringing the position to 307,754 shares worth $945K. The position accounts for ﹤0.01% of the portfolio, ranked #3302.

Two Sigma Investments first reported a position in STLN in Q4 2022 and has held it in 6 quarters since. The position peaked at $974K in Q3 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Two Sigma Investments held 307,754 shares of Starling Oncology Institute, Inc. Common Stock worth $945K as of Q1 2026.
  • Two Sigma Investments bought 45,704 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $140K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3302 holding.
  • Two Sigma Investments first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2022 and has held it in 6 quarters since.
  • Two Sigma Investments's Starling Oncology Institute, Inc. Common Stock position peaked at $974K in Q3 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.